Steering Committee
Prof. Bernd Bodenmilller

ETH Zurich
Chair of the Steering Committee

Quantitative Biomedicine

The Bodenmiller group develops and applies methods to analyse human tissues spatially and at the single cell level, and to understand disease states. In particular, they study cancer tissue to make discoveries that could improve treatment.

Prof. Federica Sallusto

ETH Zurich
Member of the Steering Committee

Medical Immunology

The Sallusto lab is focused on the understanding of the mechanisms that control T cell priming and regulate cytokine production and homing capacities. These questions are addressed primarily in the human system, where they combine the ex vivo analysis of memory T cell subsets with in vitro priming of naive T cells.

Prof. Klaas Enno Stephan

ETH Zurich and UZH
Member of the Steering Committee

Translational Neuromodeling

The Translational Neuromodeling Unit is an interdisciplinary institution with the mission to translate advances in computational neuroscience into tools for clinical practice. The TNU assembles computational scientists and clinicians under one roof and operates a dedicated research clinic for evaluating the diagnostic and prognostic utility of computational assays in prospective patient studies.

Prof. Markus Manz

University Hospital Zurich
Member of the Steering Committee

Leukemia and Lymphoma

The Experimental hematology lab is focused on haematopoietic and immune system development, homeostasis and function, as well as on hemato-lymphoid disease. They aim to gain basic knowledge and to provoke practical new strategies for clinical intervention in states of infection, immunodeficiency, autoimmunity, malignancy, and transplantation of hematopoietic cells.

Prof. Nicola Aceto

ETH Zurich
Member of the Steering Committee

Molecular Oncology

The Aceto group is interested in understanding the fundamental molecular mechanisms that drive cancer and its metastatic progression, with a particular focus on the analysis of circulating tumor cells.

Prof. Mascha Binder

University Hospital Basel
Member of the Steering Committee

Tumor Immunotherapies

The Binder lab is studying the adaptive immune system to understand B and T cell biology in health and disease. They are especially interested in immune repertoires and focus on immunotherapy of solid tumors as well as the biology and targeting of lymphoma.

Prof. Michael Detmar

ETH Zurich
Member of the Steering Committee

Pharmacogenomics

The overall goals of Prof. Detmar’s ongoing research are to identify and to characterize molecular targets controlling inflammatory and tumor angiogenesis and lymphangiogenesis.